JPRN-UMIN000021421
Completed
Phase 1
Continuous intravenous adrenomedullin therapy for patients with inflammatory bowel disease (ulcerative colitis and Crohn's disease) - Adrenomedullin therapy for patients with inflammatory bowel disease
First Department of Internal Medicine, Faculty of Medicine, University of Miyazaki0 sites10 target enrollmentMarch 11, 2016
Overview
- Phase
- Phase 1
- Intervention
- Not specified
- Conditions
- inflammatory bowel disease (ulcerative colitis and Crohn'
- Sponsor
- First Department of Internal Medicine, Faculty of Medicine, University of Miyazaki
- Enrollment
- 10
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •Patients having one or more of following conditions 1\. malignancy 2\. pre\-carcinoma lesion(s) of the intestine 3\. recommended early operation 4\. cachexia 5\. severe liver dysfunction 6\. acute myocardial infarction, unstable angina, myocarditis and stroke within 1 month 7\. active infection 8\. pregnancy 9\. other inappropriate conditions by doctor decision
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 2
Alternative therapy using continuous intravenous administration of adrenomedullin for patients with inflammatory bowel diseaseinflammatory bowel diseaseJPRN-UMIN000003230First Department of Internal Medicine, Faculty of Medicine, University of Miyazaki10
Active, not recruiting
Not Applicable
Intermittent intravenous adenosine with prolonged pain in the back of the neck with allodynia/dysaesthesia.EUCTR2004-004738-15-SEKarolinska University Hospital, Huddinge15
Completed
Not Applicable
Prolonged administration of Intravenous Medication through Midline compared to Standard peripheral intravenous cannula in childreHospitalised children requiring vascular accessAnaesthesiology - AnaestheticsACTRN12620000724976Queenland Children's Hospital128
Completed
Phase 1
Multiple-dose administration study of adrenomedulliJPRN-jRCT2080224807niversity of MIyazaki12
Active, not recruiting
Phase 1
A randomised blinded placebo controlled trial of hydrocortisone in critically ill patients with septic shockEUCTR2012-003158-10-IEThe George Institute for Global Health3,800